BRUKINSA ZANUBRUTINIB Trademark

Trademark Overview

On Wednesday, March 13, 2019, a trademark application was filed for BRUKINSA ZANUBRUTINIB with the United States Patent and Trademark Office. The USPTO has given the BRUKINSA ZANUBRUTINIB trademark a serial number of 88337582. The federal status of this trademark filing is REGISTERED as of Tuesday, January 19, 2021. This trademark is owned by BeiGene, Ltd.. The BRUKINSA ZANUBRUTINIB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
brukinsa zanubrutinib

General Information

Serial Number88337582
Word MarkBRUKINSA ZANUBRUTINIB
Filing DateWednesday, March 13, 2019
Status700 - REGISTERED
Status DateTuesday, January 19, 2021
Registration Number6252000
Registration DateTuesday, January 19, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of an image of a mountain on the left with the words "BRUKINSA" to the right and the word "ZANUBRUTINIB" below it.
NOT AVAILABLE"ZANUBRUTINIB"
Certificate of Correction for RegistrationIn the statement, line 1, "Corporation" should be deleted, and limited company (ltd.) should be inserted.
Goods and ServicesPharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 31, 2019
Primary Code005
First Use Anywhere DateThursday, November 21, 2019
First Use In Commerce DateThursday, November 21, 2019

Trademark Owner History

Party NameBEONE MEDICINES I GMBH
Party Type33 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBASEL 4051
CH
Party NameBG NC 1, LTD.
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressGRAND CAYMAN 1-1108
KY
Party NameBEONE MEDICINES LTD.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBASEL 4051
CH
Party NameBeiGene, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Saturday, March 16, 2019NEW APPLICATION ENTERED
Sunday, March 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 22, 2019ASSIGNED TO EXAMINER
Wednesday, May 29, 2019NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 15, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, November 15, 2019EXAMINERS AMENDMENT E-MAILED
Friday, November 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 15, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, November 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2019ASSIGNED TO LIE
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 4, 2020TEAS STATEMENT OF USE RECEIVED
Monday, March 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 4, 2020USE AMENDMENT FILED
Monday, March 23, 2020STATEMENT OF USE PROCESSING COMPLETE
Saturday, April 11, 2020SU - NON-FINAL ACTION - WRITTEN
Saturday, April 11, 2020NON-FINAL ACTION E-MAILED
Saturday, April 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 9, 2020SU - FINAL REFUSAL - WRITTEN
Tuesday, June 9, 2020FINAL REFUSAL E-MAILED
Tuesday, June 9, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 2, 2020EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, December 2, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, December 2, 2020EX PARTE APPEAL-INSTITUTED
Wednesday, December 2, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, December 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 17, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 18, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 19, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 19, 2021EXPARTE APPEAL TERMINATED
Thursday, January 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 3, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 4, 2021CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 9, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, July 10, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 29, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 29, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

zanubrutinib brukinsa diseases inflammatory infectious autoimmune cancer comprising treatment pharmaceuticals